Jazz Pharmaceuticals Plc (JAZZ)
169.53
+2.03
(+1.21%)
USD |
NASDAQ |
Dec 15, 16:00
169.01
-0.52
(-0.31%)
After-Hours: 05:45
Jazz Pharmaceuticals Free Cash Flow: 1.282B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Zymeworks, Inc. | -64.45M |
| Alkermes Plc | 490.87M |
| Avadel Pharmaceuticals Plc | 36.79M |
| Amarin Corp. Plc | -21.82M |
| Johnson & Johnson | 20.46B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 474.62M |
| Cash from Investing (Quarterly) | -327.80M |
| Cash from Financing (Quarterly) | -10.83M |
| Free Cash Flow Per Share (Quarterly) | 6.971 |
| Free Cash Flow to Equity (Quarterly) | 434.00M |
| Free Cash Flow to Firm (Quarterly) | 2.288B |
| Free Cash Flow Yield | 12.38% |